Mesh versus acellular dermal matrix in immediate implantbased breast reconstructione A prospective randomized trial
2016
- D. Gschwantler-Kaulich, P. Schrenk, V. Bjelic-Radisic, K. Unterrieder, C. Leser, A. Fink-Retter, M. Salama, C. Singer
Mesh versus acellular dermal matrix in immediate implantbased breast reconstructione A prospective randomized trial
This prospective, randomized, controlled, multicenter pilot study was performed at four Austrian breast cancer centers. Fifty patients with oncologic or prophylactic indication for mastectomy and IBBR were randomized to immediate IBBR with either an ADM(Protexa) or a titanized mesh (TiLOOPBra).
Da evidenziare sia il 30% di perdita di impianto nel gruppo di Protexa(contro il 7 % di tiloop),sia il miglior outcome estetico e grado di soddisfazione del gruppo Tiloop BRA.